The PRAME-AS knockout cells showed a decrease in migration, proliferation, stemness, and viability. by Zahra Hosseininia (22265113)

GSK343 decreased tumor stemness. by Laura V. Bownes (10276762)

“…Treatment with GSK343 significantly decreased tumorsphere formation by both the COA3 (A) and COA6 (B) cells, representing a decrease in stem cell-like phenotype. …”

Data_Sheet_1_Botulinum toxin A decreases neural activity in pain-related brain regions in individuals with chronic ocular pain and photophobia.docx by Nicholas Reyes (16390233)

“…Four to six weeks after BoNT-A injection, unpleasantness scores decreased (48.1 ± 33.6), but the change was not significant. …”

Data_Sheet_2_Botulinum toxin A decreases neural activity in pain-related brain regions in individuals with chronic ocular pain and photophobia.docx by Nicholas Reyes (16390233)

“…Four to six weeks after BoNT-A injection, unpleasantness scores decreased (48.1 ± 33.6), but the change was not significant. …”

Data_Sheet_1_Botulinum toxin A decreases neural activity in pain-related brain regions in individuals with chronic ocular pain and photophobia.docx by Nicholas Reyes (16390233)

“…Four to six weeks after BoNT-A injection, unpleasantness scores decreased (48.1 ± 33.6), but the change was not significant. …”

Data_Sheet_2_Botulinum toxin A decreases neural activity in pain-related brain regions in individuals with chronic ocular pain and photophobia.docx by Nicholas Reyes (16390233)

“…Four to six weeks after BoNT-A injection, unpleasantness scores decreased (48.1 ± 33.6), but the change was not significant. …”

CD47 expression is decreased in hematopoietic progenitor cells in patients with myelofibrosis by A. Nonino (6072632)

“…We compared CD47 expression in hematopoietic stem and progenitor cells of patients with MF and controls and found it to be decreased in progenitors of MF. …”

A decrease in CD44+ cells in response to hypoxia. by Daniel V. Brown (3797809)

Ketamine decreases NSC viability in a dose-dependent manner. by Shiva Mansouri (2838086)

Exogenous FGF4 decreases osteogenic differentiation of mESCs. by Sung-Ho Kook (445098)

Subjects:

Transplantation of Exendin-4 pretreated ADSCs decrease apoptosis, fibrosis, and promote angiogenesis. by Jianfeng Liu (122580)

MSCs decrease lung inflammation. by Konrad Urbanek (439073)

Running increased neural stem cell proliferation in the dentate gyrus, but did not decrease inflammation. by Kaja Falkenhain (9317016)

hESCs-CM decreased cancer cells growth. by Shufeng Zhou (398572)

Subjects:

Naloxone decreases the number of apoptotic cells induced by morphine but does not affect their profile. by Dafna Willner (605895)

Subjects:

Loss of Prox1a decreases PR production at 120 hours post-ablation. by Kellie Veen (17343374)

Effect of decrease in cumulative tear area on intraluminal flows and pressures. by Paula A. Rudenick (577138)

“…<p>Variations in flow patterns (Left) and pressure profiles (Right) for a decrease in the cumulative tear area (from 300 to 25 mm²) and resultant true lumen (TL) vasodilatation. …”

Inducible and conditional knockout (icKO) of ERK5 decreases adult OB neurogenesis. by Tan Li (404990)

Subjects:

H-MSCs^WT decrease myofibroblasts in peri-infarction region. by Panpan Chen (307628)

Subjects:

Decreased ISCs and increased goblet cells after intestinal specific loss of MLL1. by Neha Goveas (11790822)

“…<p><b>(A)</b> Kaplan-Meier survival curve. Tamoxifen was given by gavage for 6 days to mice with the genotype <i>Mll1</i>^{<i>FC/+; Vil-Cre-ERT2/+</i>} (n = 12) and <i>Mll1</i>^{<i>FC/FC; RC/+</i>} (n = 18). …”